# Mi-thos® Transcatheter Mitral Valve Replacement(First-in-Man Study)

> **NCT05784337** · NA · COMPLETED · sponsor: **Shanghai NewMed Medical Co., Ltd.** · enrollment: 11 (actual)

## Conditions studied

- Mitral Valve Regurgitation

## Interventions

- **DEVICE:** Mi-thos® Transcatheter Mitral Valve Replacement System

## Key facts

- **NCT ID:** NCT05784337
- **Lead sponsor:** Shanghai NewMed Medical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-21
- **Primary completion:** 2023-01-10
- **Final completion:** 2023-01-10
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05784337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05784337, "Mi-thos® Transcatheter Mitral Valve Replacement(First-in-Man Study)". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT05784337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*